BJ
CPRX icon

BlackRock Japan’s Catalyst Pharmaceutical CPRX Stock Holding History

BlackRock Japan’s Portfolio CPRX Stock Details CPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-3,407
Closed -$4K – 1433
2016
Q1 		$4K Hold
3,407
– – ﹤0.01% 1368
2015
Q4 		$8K Buy
3,407
+1,635
+92% +$4.68K ﹤0.01% 1289
2015
Q3 		$5K Sell
1,772
-3,750
-68% -$16.2K ﹤0.01% 1210
2015
Q2 		$23K Buy
+5,522
New +$22K ﹤0.01% 1179

Other funds holding CPRX

BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
TCM
Tanaka Capital Management New York $59.9M AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

BlackRock Japan's CPRX Position: Q2 2016 in Review

BlackRock Japan sold out of Catalyst Pharmaceutical (CPRX) in Q2 2016, closing a stake of 3,407 shares — an estimated $4K sold.

BlackRock Japan first reported a position in CPRX in Q2 2015 and held it in 4 quarters. The position peaked at $23K in Q2 2015. 62 funds tracked by Wall St. Rank hold CPRX as of Q2 2016.

  • BlackRock Japan reported no remaining Catalyst Pharmaceutical position as of Q2 2016 after selling out during the quarter.
  • BlackRock Japan sold 3,407 Catalyst Pharmaceutical shares in Q2 2016, an estimated $4K.
  • BlackRock Japan first reported a position in Catalyst Pharmaceutical in Q2 2015 and held it in 4 quarters.
  • BlackRock Japan's Catalyst Pharmaceutical position peaked at $23K in Q2 2015.
  • 62 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q2 2016.

Based on BlackRock Japan's 13F filing for Q2 2016, filed 10 Aug 2016.